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Cyclin C/Cdk3 Promotes
Rb-Dependent G0 Exit
tion of E2F responsive genes and stimulates S phase
entry.
While the mechanisms governing early and late G1
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progression are well understood, much less is knownDepartment of Medicine
about the G0 to G1 transition. G0 is generally consideredBrigham and Women’s Hospital
to be a distinct state that cells do not enter while activelyHarvard Medical School
cycling (Lajtha, 1963), implying the existence of molecu-Boston, Massachusetts 02115
lar signals that regulate the transition between G0 and
G1. By analogy to S phase progression, pocket protein
phosphorylation may also govern this phase change.
Summary
For example, p130 changes its phosphorylation status
as cells leave G0 and enter G1 (Canhoto et al., 2000;
G0 is a physiological state occupied by resting or ter- Mayol et al., 1995, 1996) in concert with shifts in the
minally differentiated cells that have exited the cell association between p130 and the E2F family members
cycle. In contrast to the well-characterized cyclin/cdk- E2F-4 and E2F-5 (Moberg et al., 1996; Sardet et al.,
mediated inactivation of pRb that controls the G1/S 1995). A specific role for pRb in G0 arrest is indicated
transition, little is known about regulation of the G0/ by the observation that acute inactivation of pRb alone
G1 transition. However, pRb is likely to participate in is sufficient for G0-arrested cells to reenter the cell
this process because its acute somatic inactivation is cycle (Sage et al., 2003). This suggests that the hypo-
sufficient for G0-arrested cells to reenter the cell cycle. or, perhaps, unphosphorylated form of pRb that appears
One physiological regulator of this event may be cyclin in G0 (Ezhevsky et al., 1997) may undergo phosphoryla-
C because its highest mRNA levels occur during G0 tion-mediated inactivation in order for cells to enter G1.
exit. Here we show that a non-cdk8-associated cellu- In fact, some of the kinases responsible for phosphory-
lar pool of cyclin C combines with cdk3 to stimulate lating un- and hypophosphorylated pRb and p130 have
pRb phosphorylation at S807/811 during the G0/G1 been identified. Cdk4 phosphorylates both pocket pro-
transition, and that this phosphorylation is required for teins early in G1 (Ezhevsky et al., 1997; Farkas et al.,
cells to exit G0 efficiently. Thus, G1 entry is regulated in 2002), however the contribution of these events to the
an analogous fashion to S phase entry, but involves a G0 to G1 transition has not been rigorously demon-
distinct cyclin/cdk combination. strated. Furthermore, mutation of all known cdk4 phos-
phorylation sites in p130 produces a protein that can
still be inactivated in a regulated manner in early G1Introduction
(Farkas et al., 2002). This suggests that other cyclin/
cdk combinations may also be active in the G0 to G1Experimentation during the past twenty years has re-
transition.sulted in a detailed mechanistic understanding of the
One possible regulator of G0 events is cyclin C be-controls that govern cell cycle progression (reviewed in
cause its highest mRNA expression levels occur duringSherr, 2000). Transition between cell cycle phases is
G0 exit (Liu et al., 1998b; Rickert et al., 1996). Cyclinregulated by a series of temporally coordinated phos-
C was identified in genetic screens for mammalian orphorylation events that target members of the pocket
Drosophila genes that could rescue a triple CLN-defi-protein family, including pRb, p107, and p130. The ki-
cient strain of S. cerevisiae (Leopold and O’Farrell, 1991;nases responsible for pocket protein phosphorylation
Lew et al., 1991). These same screens discoveredare cyclin dependent kinases (cdks), which are activated
cyclins D1 and E, and although they have found placesin part by their association with cyclins. In early G1, pRb
as regulators of cdks that have a direct effect on cellis phosphorylated to a limited extent by cdk4 and cdk6
cycle progression, cyclin C has not. Instead, it has beenin association with D-type cyclins. This “hypophosphor-
shown to regulate the activity of cdk8 (Tassan et al.,ylated” pRb binds to E2F family members thereby pre-
1995), which phosphorylates the C-terminal domainventing transcription of E2F-responsive genes both by
(CTD) of RNA polymerase II (Leclerc et al., 1996; Rickertphysically blocking E2F’s transactivating domain and
et al., 1996). This function is consistent with the close
by recruiting chromatin-modifying enzymes that actively
structural similarities between cyclin C/cdk8 and the
repress transcription (Trimarchi and Lees, 2002). In mid-
SRB11/SRB10 complex which is a component of the S.
G1, additional cdk4/6 phosphorylation releases some cerevisiae RNA polymerase II holoenzyme (Liao et al.,
of the associated proteins, and in late G1 cyclin E/cdk2 1995) and is required for optimal CTD phosphorylation
phosphorylates pRb at additional sites to produce hy- (Dahmus, 1996; Serizawa et al., 1995). Cyclin C/cdk8
perphosphorylated pRb, an isoform that no longer has also phosphorylates cyclin H, which negatively regu-
affinity for E2F. Dissociation from pRb removes both the lates TFIIH (Akoulitchev et al., 2000).
blockade of E2F’s transactivation domain and the nidus Although cyclin C’s contribution to transcriptional reg-
for enzymes that produce transcriptionally silent chro- ulation is well established, this activity does not readily
matin. This combination of events activates transcrip- explain its capacity to rescue G1 cyclin deficiency in
yeast. On one hand, cyclin C’s ability to stimulate CDC28
in S. cerevisiae may simply be a consequence of the*Correspondence: barrett_rollins@dfci.harvard.edu
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same structurally conserved cyclin domains that acti- vated cell sorting (Darzynkiewicz and Traganos, 1990;
Ladd et al., 1997). Cells with 2n DNA content and lowvate cdk8 in its native mammalian or insect contexts. On
the other hand, cyclin C may also have an unappreciated RNA content are resting and in G0 while cells with 2n
DNA and higher RNA content are in G1. By this measure,G0/G1 cyclin activity. In this study, we tested cyclin C’s
ability to regulate events in G0 and early G1. We found expression of pRb alone in SAOS-2 cells placed 33–36%
of cells in G0 (Figure 2C). However, overexpression ofthat during exit from G0, cyclin C directs pRb phosphor-
ylation in a temporal pattern that precedes pRb phos- cyclin C along with pRb reduced the proportion of G0
cells to 12%. Conversely, suppression of endogenousphorylation by cyclin D/cdk4, cyclin D/cdk6, and cyclin
E/cdk2. Furthermore, this activity does not involve cdk8 cyclin C using RNAi (Figure 2A) increased the propor-
tion of cells in G0 to 49% (Figure 2C). Overexpressionbut rather is mediated by cdk3, and targets specific pRb
substrate sites that must be phosphorylated in order for of cyclin C without pRb did not alter RNA content in
SAOS-2 cells, nor did overexpression of cyclin C in expo-cells to exit G0. Together, these results indicate that
cyclin C/cdk3 plays an important role in regulating the nentially growing T98G cells, indicating that cyclin C
does not stimulate nonspecific enhancement of RNAG0 to G1 transition and does so, in part, through specific
phosphorylation of pRb. synthesis (data not shown).
Cell cycle phase was also determined by monitoring
patterns of G1-specific gene expression. Cells trans-Results
fected with Rb alone expressed no detectable c-fos,
thymidine kinase, or DHFR, and low levels of E2F-1Cyclin C-Associated pRb Kinase Activity
mRNAs (Figure 2D). Cotransfection of Rb with cyclin CTo test whether cyclin C has an associated pRb kinase
led to substantial increases in levels of each of theseactivity that varies with cell cycle phase, we examined
mRNAs. That cyclin C did not induce a nonspecific,human T98G cells that express wild-type pRb and can
generalized increase in mRNA transcription was againbe arrested in G0. After three days of serum deprivation,
indicated by the unchanged levels of cyclin E andT98G cells were stimulated with serum and lysates were
GAPDH expression in cells transfected with Rb or Rbcollected at various times thereafter. Cyclin C immune
plus cyclin C (Figure 2D).precipitates from these lysates had pRb kinase activity
that was present at low levels in G0 cells, increased in
early G1, decreased in late G1 and S phases, and then G0 Exit Requires pRb Phosphorylation at S807/811
Coexpression of cyclin C and pRb in SAOS-2 cells stimu-reappeared as cells reentered G1 (Figure 1A). This pat-
tern of activity was precisely the inverse of pRb kinase lated pRb phosphate incorporation (data not shown).
Using mass spectrometric and phosphospecific anti-activities associated with cyclins D1 and E, which in-
creased at the G1/S boundary (Figure 1A). body analyses, we identified S807/811 as being among
the sites whose phosphorylation was enhanced byAs the pRb-kinase activity would predict, endogenous
cyclin C forms complexes with endogenous pRb. In se- cyclin C expression. Suppression of endogenous cyclin
C by RNAi reversed constitutive S807/811 phosphoryla-rum-stimulated T98G cells, cyclin C preferentially bound
to hypophosphorylated pRb in G0/early G1 and in late tion in transfected SAOS-2 cells and overexpression
of cyclin C enhanced it (Figure 3A). Cyclin C immuneG2/M, coincident with periods of maximal pRb kinase
activity (Figure 1B). In confirmation of the cyclin C/pRb precipitates from SAOS-2 cells transfected with cyclin
C and pRb phosphorylated GST-Rb at S807/811 in vitrointeraction, cyclin C immune precipitates from 3T3 cells
contained pRb (Figure 1C). The former interaction was indicating that the cyclin C-associated kinase activity can
directly phosphorylate pRb at those sites (Figure 3B).specifically prevented by a competing cyclin C peptide.
Also, the nominal pRb band of 110 kD only appeared To test the functional significance of S807/811 phos-
phorylation, we constructed pRb variants in which S807in lysates from wild-type 3T3 cells and not 3T3 cells from
Rb/ mice (Figure 1C). Similarly specific interactions and S811 were changed individually or in tandem to
nonphosphorylatable amino acids. Coexpression of ei-occurred in human cells i.e., the presence of pRb in
cyclin C immune precipitates from Rb-positive T98G ther variant with cyclin C reduced the phosphospecific
antibody signal and expression of the double mutantcells, and its absence in cyclin C immune precipitates
from Rb-negative SAOS-2 cells (Figure 1D). (Evidence resulted in no signal (Figure 3C). Expression of the dou-
ble mutant in SAOS-2 cells promoted G0/G1 arrest tofor the specificity of the anticyclin-C antibody is shown
in Supplemental Data available at http://www.cell.com/ the same extent as wild-type pRb, as reported by others
(Knudsen and Wang, 1996), as did expression of eithercgi/content/full/117/2/239/DC1.)
single mutant (Figure 3D). However, expression of either
single mutant along with cyclin C increased the propor-Cyclin C Promotes G0 Exit
tion of cells in G0 to 30% (Figure 3E). CoexpressionThe pRb kinase activities associated with G1 cyclins
of the double mutant with cyclin C increased the G0stimulate S phase entry by inactivating pRb. However,
proportion to 38%, the same level observed when pRbdespite its associated pRb kinase activity, cotransfec-
was expressed without cyclin C (Figure 2C), indicatingtion of cyclin C with pRb in SAOS-2 cells did not promote
that the double mutant had a completely suppressiveS phase entry (Figures 2A and 2B). Because of the timing
phenotype.of cyclin C-associated pRb kinase activity, we consid-
ered the possibility that its effects might be occur prior
to those of G1 cyclins i.e., at the G0/G1 transition. One Cdk8 Is Not the Cyclin C-Associated pRb Kinase
Until now, cdk8 was the only kinase associated withtechnique for assessing G0 status is simultaneous quan-
titation of DNA and RNA content by fluorescence acti- cyclin C. Surprisingly, then, cdk8 immune precipitates
Cyclin C/cdk3 and G0 Exit
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Figure 1. Cyclin C-Associated pRb Kinase Activity
(A) T98G cells were placed in serum-free medium for three days then stimulated with 15% FBS. Lysates were prepared at the indicated times
after serum stimulation and subjected to immune precipitation using anticyclin C, anticyclin D1, and anticyclin E. Precipitates were tested for
in vitro kinase activity using GST-Rb(379–928) as substrate (IPK). Kinase reactions were analyzed by SDS-PAGE followed by transfer to PVDF
membranes. After exposing the membranes to X-ray film, they were probed using anti-GST or anticyclin C. Cells at each time point were also
analyzed for DNA content and the proportion of cells with a G1, S, or G2/M DNA content is indicated. Exposure time for the cyclin D1 and
cyclin E blots was overnight while the exposure time for the cyclin C blot was 30 min.
(B) T98G cells were placed in serum-free medium for 72 hr and then restimulated with 15% FBS. Lysates were prepared at the indicated
times after restimulation and analyzed by immunoblot using anti-pRb (upper image), by immune precipitation using anticyclin C followed by
immunoblot using anti-pRb (middle image), or by immunoblot using anticyclin C. An aliquot of cells from each time point was analyzed for
DNA content by FACS and the proportion of cells with a G1, S, or G2/M DNA content is indicated.
(C) Upper image, Murine 3T3 fibroblasts were placed in 0.1% FBS for three days, then stimulated with 15% FBS for 6 hr at which time lysates
were prepared. Lysates were subjected to immune precipitation using anticyclin C (C), anticyclin C with a competing cyclin C peptide (C 
C pep), anticyclin C with a nonspecific peptide (C  NS pep), anticyclin D1 (D1), anticyclin D1 with the cyclin C peptide (D1  C pep), anticyclin
D3 (D3), anticyclin D3 with the cyclin C peptide (D3  C pep), and anti-Rb G3-245 (Rb). Immune precipitates were analyzed by immunoblot
using anti-Rb. Normal rabbit IgG (NR IgG) served as an isospecific control for anticyclin C, anticyclin-D1, and anticyclin-D3; anti-FLAG IgG1
(FLAG) served as an isotype control for anti-Rb. Lower image, lysates from wild-type 3T3 cells (/) and 3T3 cells from Rb/ embryos (/)
were prepared and subjected to immune precipitation using anticyclin C, anticyclin D3, and anti-Rb. Precipitates and whole lysates were
analyzed by immunoblot using anti-Rb, anticyclin C, and anticyclin D3 as indicated. Normal rabbit IgG (NR IgG) and anti-FLAG (FLAG) served
as controls.
(D) Upper image, T98G cells were placed in serum-free medium for three days, then stimulated with 15% FBS for 6 hr at which time lysates
were prepared. Lysates were subjected to immune precipitation using antibodies and peptides described in (C). Precipitates were analyzed
by immunoblot using anti-Rb. Lower image, Lysates from Rb T98G cells (T) and Rb- SAOS-2 cells (S) were prepared and subjected to immune
precipitation using the antibodies described in (C). Precipitates and lysates were analyzed by immunoblot using anti-Rb, anticyclin C, and
anticyclin D3.
from T98G cells were unable to phosphorylate GST-pRb Cyclin C Forms Complexes with cdk3
to Phosphorylate pRb(Figure 4A) despite the presence of cdk8 in the anticyclin
C precipitate (Figure 4B). Consistent with cdk8’s lack of In preliminary work, we found that cyclin C bound to a
protein from cell extracts that was recognized by anti-pRb kinase activity, we found no evidence for pRb/cdk8
complexes: no pRb was detected in anti-cdk8 precipi- PSTAIR antibodies. Because this domain is conserved
in several cdks, including cdk3, and because cdk3 hastates and no cdk8 was detected in anti-pRb precipitates
(Figure 4B). Furthermore, although cdk8 depletion pre- effects on cell cycle progression (Meyerson et al., 1992;
van den Heuvel and Harlow, 1993), we tested the possi-vented anticyclin C precipitates from phosphorylating a
peptide derived from the RNA polymerase II C-terminal bility that it might be a cyclin C-associated kinase. Since
endogenous cdk3 levels are extremely low in most celldomain, it did not alter pRb kinase activity (Figure 4C).
Thus, cdk8 is not the cyclin C-associated Rb kinase. types, we ectopically expressed FLAG-tagged cyclin C
Cell
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Figure 2. Cyclin C Promotes G0 Exit
(A) SAOS-2 cells were cotransfected with CD19 and: Rb and cyclin C; Rb and a vector control for the cyclin C expression vector (V1); nothing
(mock); Rb and shC (an expression vector encoding an shRNA directed against cyclin C); and Rb and the vector control for the shC expression
vector (V2). Immune blotting of extracts from CD19 cells was performed using the indicated antibodies. (Evidence that all three bands
recognized by the anticyclin C antibody are cyclin C-derived is presented in Supplemental Data available on Cell website.)
(B) SAOS-2 cells were cotransfected with eGFP and the indicated plasmids described in (A) as well as vector alone (V1) and cyclin D1  Rb
(D1  Rb). DNA content of eGFP cells was determined by PI staining and FACS analysis. Left, representative FACS profiles; right, combined
results of 4 independent experiments.
(C) SAOS-2 cells were cotransfected with a plasmid expressing CD19 and the indicated plasmids. Forty-eight hr later, cells were stained with
Hoechst dye, Pyronin Y, and anti-CD19. Left, dot plots of Hoechst/Pyronin Y staining in CD19 SAOS-2 cells transfected with the indicated
plasmids. The G0 quadrant was defined by cells with a 2n DNA content that had an RNA content lower than cells with 2n DNA (i.e., S 
G2/M). Right, combined results from four independent experiments. (*p  0.0001, **p  0.02 by Student’s two-tailed t test.)
(D) SAOS-2 cells were cotransfected with CD19 and the indicated plasmids. Forty-eight hr later, RNA was extracted from CD19 cells and
analyzed by RT-PCR for the indicated mRNAs.
and HA-tagged cdk3 in SAOS-2 cells and performed nant-negative cdk2 (Figure 5C). Suppression of cdk3
expression by RNAi in T98G cells reduced the levels ofcoimmune precipitation experiments. Anticyclin C pre-
cipitates contained HA-tagged cdk3, and anti-cdk3 pre- endogenous pRb S807/811 phosphorylation during the
G0/G1 transition, and abrogated the S807/811 kinasecipitates (using three different antibodies) contained
cyclin C (both endogenous and ectopically expressed) activity in cyclin C immune precipitates (Figure 5D). Thus,
cdk3 is the endogenous cyclin C partner that phosphory-(Figure 5A). The specificity of this interaction was dem-
onstrated by the absence of interactions between co- lates pRb at S807/811.
transfected FLAG-tagged cyclin C and HA-tagged cdk2
(Figure 5B). Cdk3 Promotes G0 Exit
As expected, neither dominant-negative cdk3, cdk2, norOverexpression of cdk3 with cyclin C in SAOS-2 cells
led to enhanced phosphorylation of pRb at S807/811, cdk4 had any effect on S phase entry by SAOS-2 cells
coexpressing Rb and cyclin C (Figure 6A). However,and overexpression of dominant-negative cdk3, with or
without coexpressed cyclin C, completely prevented it expression of dominant-negative cdk3 along with pRb
and cyclin C increased the proportion of cells with 2n(Figure 5C). Although S807/811 is also a cdk4 substrate,
expression of dominant-negative cdk4 did not prevent DNA content that are in G0 to 83% (Figure 6B). Domi-
nant-negative cdk2 or cdk4 had no effect on G0 status.S807/811 phosphorylation, nor did expression of domi-
Cyclin C/cdk3 and G0 Exit
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Figure 3. Cyclin C-Induced G0 Exit Requires pRb Phosphorylation at S807/811
(A) SAOS-2 cells were transfected with CD19, Rb and a plasmid encoding shRNA directed against cyclin C (shC), or Rb and a cyclin C
expression vector. (V1 is a vector control for cyclin C; V2 is a vector control for shRNA.) Lysates from CD19 cells were analyzed by immunoblot
for cyclin C and tubulin. (Note expression of endogenous cyclin C in the vector control lanes and its loss in the shRNA lane). Phosphorylation
status of Rb at S807/811 was determined by immunoblot using a phosphospecific antibody. Mock, mock-transfected SAOS-2 cells; T98G,
T98G lysates as a positive control for the phosphospecific Rb Ab.
(B) Lysates of SAOS-2 cells transfected with cyclin C and Rb were subjected to immune precipitation using anticyclin C (with or without a
competing peptide) or control normal rabbit IgG (NR IgG). Precipitates were mixed with GST-Rb and the products of an in vitro kinase reaction
were analyzed by immunoblot (IB) using S807/811 phosphospecific Rb antibody or anti-GST.
(C) SAOS-2 cells were transfected with cyclin C and Rb or the indicated nonphosphorylatable Rb variants. After 48 hr, lysates were analyzed
by immunoblot for phosphorylation at S807/811, for total expression of pRb, for total expression of cyclin C, and for tubulin.
(D) PI staining and FACS analysis of SAOS-2 cells transfected with eGFP and the indicated nonphosphorylatable pRb variants. Left, representa-
tive FACS profiles; right, combined results of four independent experiments.
(E) DNA/RNA analysis of SAOS-2 cells expressing either the singly or doubly mutated Rb variants along with cyclin C. Left, representative
FACS profiles; right, combined results of four independent experiments. (p  0.00005 comparing C  Rb to C  807A or C  811G, p 
0.002 comparing C  807A/811G to C  807A or C  811G by Student’s two-tailed t-test).
To examine the effects of endogenous cyclin C/cdk3 after serum stimulation, 50% of cdk3-expressing wild-
type cells were in G0 compared to 90% of control trans-on the G0/G1 transition, expression of cyclin C or cdk3
was suppressed by RNAi in G0-arrested T98G cells. fected wild-type cells (p  0.0005 by Student’s t-test);
at 4 hr only 10% of cdk3-expressing cells were in G0Suppression of cyclin C delayed serum-induced S phase
entry by 8 hr, and this delay was entirely the result of compared to 70% of control cells (p  0.006). By com-
parison, although cdk3 expression appeared to slightlyan 8 hr delay in G0 exit (Figure 7A). Suppression of cdk3
produced a nearly identical result (Figure 7B). Although reduce the proportion of Rb/ 3T3 cells in G0, none
of the differences with control-transfected cells werethe data of Figures 3–6 suggest that pRb is the relevant
cdk3 target, we obtained additional confirmation by significant. Thus, cdk3’s ability to promote G0 exit de-
pends on the presence of pRb. Furthermore, even priorcomparing the effects of cdk3 expression on G0 exit in
wild-type versus Rb/ 3T3 cells. Restoring cdk3 expres- to serum stimulation, a lower proportion of Rb/ 3T3
cells were in G0 compared to wild-type 3T3 cells, andsion to wild-type 3T3 cells (which do not express endog-
enous cdk3) accelerated G0 exit (Figure 7C). At 2 hr this difference persisted at 2 hr and 4 hr after serum
Cell
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stimulation. Similar differences were observed in the
cdk3-transfected cells. Thus, the absence of pRb im-
pairs G0 arrest.
Discussion
Motivated by the possibility that cyclin C might regulate
mammalian cell cycle progression, we have demon-
strated that, similar to G1 cyclins, cyclin C forms com-
plexes with pRb and stimulates its phosphorylation.
However, cyclin C-directed pRb phosphorylation occurs
earlier in the cell cycle than authentic G1 cyclin-directed
activities and does not promote S phase entry. Rather,
cyclin C stimulates cdk3-mediated phosphorylation of
pRb at S807/811 (at a minimum), and this activity is
required for efficient transition from G0 to G1.
Although cyclin C was cloned on the basis of its ability
to rescue G1 cyclin-deficient yeast (Leopold and O’Far-
rell, 1991; Lew et al., 1991), subsequent analyses have
provided little support for its mammalian G1 cyclin activ-
ity. One report suggested that in vitro translated cyclin
C might bind to pRb with low affinity (Dowdy et al., 1993),
but another indicated that cyclin C did not stimulate
pRb hyperphosphorylation in vivo (although the authors
conceded their inability to detect cyclin C protein in
transfectants) (Hinds et al., 1992). Instead, cyclin C has
been extensively characterized as a component of the
RNA polymerase II holoenzyme (Leclerc et al., 1996;
Rickert et al., 1996; Tassan et al., 1995). Homologies
between cyclin C/cdk 8 and the SRB11/SRB10 complex
in S. cerevisiae, which is required for proper CTD phos-
phorylation and RNA polymerase II function (Liao et al.,
1995), have further steered attention away from cyclin
C’s potential contributions to cell cycle regulation. How-
ever, IL-3 treatment of resting BAF-B03 murine pro-B
cells induced cyclin C expression as cells reentered the
cycle, and while ectopic expression of cyclin C alone
had no effect on BAF-B03 cell proliferation, coexpres-
sion with c-Myc stimulated IL-3-independent growth
(Liu et al., 1998b). Furthermore, these cell cycle effects
(as well as others; Liu et al., 1998a) were cdk8-indepen-
dent, suggesting that they did not occur by means of
CTD phosphorylation.
Our present work provides direct support for cyclin
Figure 4. The Cyclin C-Associated pRb Kinase Is Not cdk8
C’s role as a physiological cell cycle regulator, in particu-
lar during the G0 to G1 transition. Our inference is based
on cyclin C’s effects on G1-specific gene expression(A) Lysates were prepared from T98G cells that had been placed in
serum-free medium for three days then stimulated with 15% FBS and on an assay that demonstrates cyclin C-induced
for 6 hr. Immune precipitations were performed using anticyclin C increase in total RNA abundance in cells with a 2n DNA
(C), anticyclin C with a competing cyclin C peptide (C  pep), or content. We chose the latter assay because it had been
anti-cdk8 (cdk8). Precipitates were tested for their ability to phos-
validated in a system with a well-characterized G0phorylate GST or GST-Rb(379–928). Cyclin C precipitates phosphor-
phase, namely resting hematopoietic stem cells (Laddylated GST-Rb(379–928), but not GST alone. Normal rabbit IgG (NR
IgG) was a control for anticyclin C; normal goat IgG (NG IgG) was
a control for anti-cdk8.
(B) Lysates were prepared from T98G cells as described in (A), and
subjected to immune precipitation using anti-cdk8 (cdk8), anti-Rb with anti-cdk8 (ID, immune depleted using the anti-cdk8 or nonspe-
(Rb), anticyclin C (C), and anticyclin C with a cyclin C competing cific normal goat IgG (NS) as a control). Cyclin C immune precipitates
peptide (C  pep). Precipitates were analyzed by immunoblot using from lysates depleted using anti-cdk8 or nonspecific normal goat
anti-Rb or anti-cdk8. The lower band in the anti-cdk8 immunoblot IgG (NS) were tested for in vitro kinase activity (IPK) using GST-Rb
of the cyclin C immune precipitation is nonspecific (note its persis- or a tandemly repeated CTD peptide as substrate. Immune blot
tence in the C pep lane and its absence from the cdk8 immune (IB) using anti-GST indicated that equal amounts of GST-Rb were
precipitate). Anti-FLAG was used as an isotype control for anti-Rb; present in the kinase assays in lanes 2 and 3. As a control for
other controls were as described in (A). nonspecific phosphorylation, GST-Rb was omitted from the reac-
(C) T98G lysates were depleted of cdk8 by two rounds of incubation tions in lanes 1 and 4.
Cyclin C/cdk3 and G0 Exit
245
Figure 5. The Cyclin C-Associated pRb Kinase Is cdk3
(A) SAOS-2 cells were cotransfected with FLAG-tagged cyclin C and HA-tagged cdk3, and lysates were subjected to immune precipitation
followed by immune blot analysis. Left, anticyclin C precipitates analyzed by anti-HA blot (NR IgG, normal rabbit IgG as a control for both
anti-cdk3 and anticyclin C antibodies). Right, precipitates using three different anti-cdk3 antibodies (denoted A, B, and C) analyzed by anticyclin
C blot (NR IgG, was used as a control for the anti-cdk3 antibodies).
(B) SAOS-2 cells were cotransfected with FLAG-tagged cyclin C and HA-tagged cdk2 or HA-tagged cdk3. Left, lysates were subjected to
immune precipitation using the indicated antibodies and precipitates were analyzed by anti-FLAG immune blot to detect the presence of
ectopic cyclin C. (NR IgG was used as a control for the anti-HA and anti-cdk3 antibodies; NM IgG, normal mouse IgG, was used as a control
for the anti-cdk2 antibody). Right, total lysates were analyzed by immune blot to document levels of ectopic protein expression.
(C) SAOS-2 cells were cotransfected with Rb, cyclin C, HA-tagged wild-type cdk3 (cdk3-HA), HA-tagged dominant- negative cdk3 (dncdk3-
HA), HA-tagged dominant-negative cdk4 (dncdk4-HA), HA-tagged dominant-negative cdk2 (dncdk2-HA) or control vectors (V). Lysates were
analyzed by immunoblot.
(D) G0-arrested T98G cells were transfected with siRNA oligonucleotides directed against cdk3 or control oligonucleotides. Forty-eight hr
later, cells were stimulated for 6 hr with 15% FBS and lysates were subjected to immune precipitation using anticyclin C or anti-cdk3 in the
presence and absence of a competing cdk3 peptide. In vitro kinase reactions were performed using GST-Rb as substrate. The ability of the
precipitates to phosphorylate GST-Rb at S807/811 was determined by immunoblot. Whole-cell lysates were also examined for pRb phosphoryla-
tion at S807/811, total pRb, and total cdk3.
et al., 1997). Additional validation comes from our own immediate entry by control cells) so that the G1-to-S
transition time remained unchanged at 20 hr. Thus, asobservation that suppressing cyclin C or cdk3 in T98G
cells resulted in an 8 hr delay in G0 exit after serum expected, G1-to-S transition time was the same in
siRNA-treated cells as it was in control cells, and theirstimulation. The existence of G0 was originally inferred
because arrested cells stimulated to reenter the cell overall delay in S phase entry is evidence for time spent
in G0. Furthermore, the inferred duration of G0 in siRNA-cycle took the same time to reach S phase that actively
cycling cells took to traverse from M to S. Therefore, it treated cells, 8 hr, is reflected precisely by the time
during which the RNA/DNA ratio remains low, indicatingwas thought that resting cells must have been in a differ-
ent state i.e., distinct from G1, when they were resting that this assay accurately identifies the G0 state.
Given the fact that cyclin C/cdk 8 exerts important(Lajtha, 1963). In the experiments presented here (Fig-
ures 7A and 7B), S phase entry occurred 20 hr after effects on RNA polymerase II, what is the likelihood that
cyclin C’s influence on RNA abundance during cell cyclecontrol cells were treated with serum. When cyclin C or
cdk3 were suppressed by RNAi, cells entered S phase progression might still be mediated through cdk8’s CTD
kinase activity? This is unlikely for at least two reasons.28 hr after serum stimulation. In fact, though, according
to the RNA/DNA assay, these cells did not enter G1 First, these shifts in bulk RNA content reflect changes
in ribosomal RNA abundance that depend on the activi-until 8 hr after serum stimulation (as opposed to almost
Cell
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Figure 6. Dominant-Negative cdk3 Blocks
G0 Exit
(A) SAOS-2 cells were cotransfected with
CD19, pRb, cyclin C, dominant-negative cdk3
(dncdk3), dominant-negative cdk2 (dncdk2),
dominant-negative cdk4 (dncdk4) or control
vectors (V). DNA content was monitored in
CD19 positive cells by Hoechst staining fol-
lowed by FACS analysis. Left, representative
FACS profiles; right, combined results of four
independent experiments.
(B) SAOS-2 cells transfected as described in
(A) were stained with Hoechst dye and Pyro-
nin Y, and CD19 positive cells were analyzed
by FACS. Left, representative FACS profiles;
right, combined results of four independent
experiments.
ties of RNA polymerases I and III, not II. In that regard, The involvement of cdk3 in this process rather than
cdk8 is surprising, although consistent with previouslyit is worth noting that pRb directly represses the activi-
ties of RNA polymerases I and III (Cavanaugh et al., 1995; reported cdk8-independent effects of cyclin C in BAF-
B03 cells (Liu et al., 1998b). Like cyclin C, cdk3 is struc-White et al., 1996). This suggests that the regulation of
cell cycle entry from G0 is tightly coordinated with the turally related to other cell cycle regulators (Meyerson
et al., 1992), and a variety of observations suggest that ittranscriptional machinery and that phosphorylation of
pRb by cyclin C/cdk3 inactivates both its blockade of can influence cell cycle progression. Cdk3 complements
CDC28 in S. cerevisiae (Meyerson et al., 1992), and dom-G0 exit and its suppression of rRNA synthesis. These
observations are consistent with the notion that G0 is inant-negative cdk3 causes growth arrest in SAOS-2
cells prior to S phase entry (van den Heuvel and Harlow,a resting, quiescent state comparable to stationary
phase in yeast (Herman, 2002), and that resumption of 1993). However, phosphorylation of pRb by cdk3 is in-
sufficient to inactivate its suppression of S phase entryactive cell cycling is predicated on rearming the cell for
translation (Pardee, 1989). While the tandem control of (Connell-Crowley et al., 1997). Rather, our data indicate
that cdk3 is stimulated by cyclin C in G0 to phosphory-these events might not be unexpected, it is surprising
that pRb itself contributes to regulating both. The fact late pRb at S807/811 to promote G1 entry. Notably,
dominant-negative cdk3 placed a higher proportion ofthat part of the tumor suppressor activity of p19ARF may
involve suppression of rRNA synthesis indicates that SAOS-2 cells in G0 than shRNA directed against cyclin
C (compare Figure 6B to Figure 2C). Thus, cdk3 maythe coordination of cell cycle progression and ribosome
synthesis through a single molecular switch point may interact with additional regulatory subunits or may be
activated to some extent even without associating withbe a general phenomenon (Sugimoto et al., 2003). The
cyclin C/cdk3-mediated increase in RNA abundance is cyclin C in SAOS-2 cells. However, in T98G cells, sup-
pression of cyclin C or cdk3 placed the same proportionnot a nonspecific effect because expression of cyclin
C alone i.e., without Rb, in SAOS-2 cells and in exponen- of cells in G0. In this more physiological cell type, cyclin
C and cdk3 may be specifically matched.tially growing T98G cells did not result in increased
RNA content. Despite our evidence implicating cdk3 in the G0 to
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Figure 7. Endogenous Cyclin C and cdk3 Target pRb to Promote Efficient G0 Exit
(A) T98G cells were serum-starved for 72 hr then transfected with siRNA oligonucleotides directed against cyclin C (siRNA-C) or control
oligonucleotides (Control). After an additional 48 hr in serum-free medium, transfected cells were treated with 15% FCS. At the indicated
times, some cells were collected and extracts were analyzed by immunoblot for Rb phosphorylation at S807/811, total Rb, cyclin C, and
tubulin (upper image). Additional cells were analyzed for DNA content by propidium iodide staining and the proportion of cells in S phase
was determined (middle image). A final group of cells was analyzed for RNA and DNA content and the proportion of cells in G0 was determined
(lower image). Results in the lower images were derived from four independent experiments; error bars, standard deviation.
(B) Serum starved T98G cells were treated exactly as described in (A), except that RNA oligonucleotides directed against cdk3 were used
and cdk3 levels were determined in cell lysates.
(C) 3T3 cells from wild-type or Rb/ mice of the same strain were transfected with a control vector or a cdk3 expression vector along with eGFP.
Thirty-six hr later, cells were placed in 0.1% serum for two days and then stimulated with 15% FBS. Left, lysates were collected at the indicated
times and analyzed by immunoblot using the indicated antibodies. (The phosphospecific S807/811 pRb antibody raised against the human
protein recognizes murine pRb phosphorylated at the analogous positions, S800/804.) Right, parallel cultures were harvested at the same
time points and eGFP-positive cells were analyzed for RNA and DNA content to determine the proportion of cells in G0. Combined results
are shown for three independent experiments; error bars, standard deviation; outcomes of tests for statistical significance are described in
the text.
G1 transition, its essential contribution to this process cdk3, it is likely that the “rescue” of these mice reflects
functional redundancy among cdks. Nonetheless, com-is questioned by the fact that most inbred laboratory
mouse strains lack functional cdk3 (Ye et al., 2001). pensation for loss of cdk3 may not be complete, be-
cause overexpressing cdk3 accelerated G0 exit in 3T3While this may cast doubt on an essential function for
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cells from cdk3-deficient mice. Thus, the effects of cdk3 underway which may reveal additional relevant phos-
loss are still detectable in cdk3-deficient mouse cells, phorylation sites.
and functional redundancy among the cdks is not fully Finally, it is curious that despite the robust ability
compensatory for stimulating G0 exit. of human cyclin C to rescue G1 cyclin-deficient yeast,
This point is also relevant in considering our observa- functional analyses of the nominal yeast homolog have
tion that suppression of cyclin C or cdk3 in T98G cells consistently identified its associated CTD kinase activ-
resulted in only a transient inability to exit G0. Again, ity, an effect that appears to have little to do with cell
there may be redundant specificities in the cyclin/cdk cycle regulation. A possible explanation would be that
system, which could achieve some of the same regula- SRB11/SSN8 is simply not able to model mammalian
tory effects as cyclin C/cdk3. However, the 8 hr delay cyclin C. For example, S. cerevisiae SSN8 cannot rescue
in G0 exit in the absence of cyclin C or cdk3 indicates triple CLN-deficient S. cerevisiae, and human cyclin C
that cyclin C/cdk3 promotes G0 exit much more effi- cannot complement an ssn8 mutant (Kuchin et al., 1995).
ciently than putatively redundant kinases. Similar delays Thus, SRB11/SSN8 and eukaryotic cyclin C are not func-
rather than permanent blocks to S phase entry have tionally interchangeable even though human cyclin C is
been observed when G1 cyclins are targeted by intracel- clearly active in yeast (Lew et al., 1991). Whether this is
lular antibody administration (Pagano et al., 1992) or due to the presence of unique pathways in eukaryotes
when cdk4 is inactivated by targeted disruption (Tsutsui or to the possibility that SRB11/SSN8 is not a functional
et al., 1999). In fact, a potential source of redundancy ortholog of cyclin C remains to be established.
in our system might be cdk4 because it also phosphory-
lates pRb at S807/811 (Brantley and Harbour, 2000; Pan Experimental Procedures
et al., 1998). Phosphorylation at these sites dissociates
Cell Culturec-abl from the C domain of pRb (Knudsen and Wang,
All cells were grown in Dulbecco’s Modified Eagle Medium (MDEM)1996) and prevents the binding of LXCXE proteins (Har-
(GIBCO) containing 10% fetal bovine serum (FBS), 10 units/ml peni-bour et al., 1999). It also contributes to the conforma-
cillin (Sigma) and 0.1 g/ml streptomycin (Sigma). For synchroniza-
tional change that permits S567 phosphorylation and tion studies, cells were incubated in medium containing 0.1% FBS
disruption of E2F binding (Harbour et al., 1999). Whether (3T3 cells) or no FBS (T98G and SAOS-2 cells) for 72 hr, then stimu-
any of these steps is required for inactivating pRb’s lated with medium containing 15% FBS. For some experiments,
cells were metabolically radiolabeled by incubation in phosphate-suppression of G0 to G1 transition remains to be deter-
free medium for 1 hr followed by 0.42 mCi/ml [32P]orthophosphatemined. However, a more likely scenario is that cyclin
(285 Ci/mg, PerkinElmer Life Sciences, Inc., Boston, MA) for 3 hr.C/cdk3-mediated phosphorylation at S807/811 in G0-
3T3 cells from Rb/ and Rb/ mice in the same strain backgrounds
arrested cells produces effects specific for G0 exit. In (C57Bl/6  129Sv) were provided by Dr. W. Kaelin (Dana-Farber
contrast, when cells are actively cycling, D-cyclin/cdk4 Cancer Institute).
phosphorylation of these sites promotes S phase entry
and cyclin C/cdk3 would not be needed again for pRb Plasmids and Transfections
cDNAs encoding HA-tagged human Rb, human CD19, and eGFP ininactivation unless cells reenter G0. In further support
pcDNA3, and cyclin D1 in pSG5, were provided by Dr. J. De Caprioof this model is the fact that S807/811 phosphorylation
(Dana-Farber Cancer Institute, Boston, MA). HA-tagged cdk2, domi-occurs within 3 hr of stimulating G0-arrested T lympho-
nant-negative cdk2, dominant-negative cdk3, and dominant-nega-cytes with anti-CD3/anti-CD28 (Lea et al., 2003).
tive cdk4 in pCMV-Bam-neo were provided by Dr. S van den Heuvel
The importance of pRb as a cdk3 target in G0 exit is (Massachusetts General Hospital, Boston, MA). Human wild-type
supported by our cotransfection experiments in SAOS-2 cdk3 (a gift of Dr. M. Meyerson, Dana-Farber Cancer Institute, Bos-
cells but is more directly confirmed by examination of ton, MA) was constructed by inserting the cDNA into vector,
pRcCMV. Human cyclin C cDNA was a gift from Dr. Steven ReedRb/ 3T3 cells. Unlike wild-type cells, Rb/ 3T3 cells
(Scripps Research Institute, La Jolla, CA). Sequences encoding thewere not stimulated to exit G0 by ectopic expression of
FLAG epitope were introduced at the C-terminus of cyclin C usingcdk3. pRb’s suppression of G0 exit is further supported
standard techniques (Zhang et al., 1994). FLAG-tagged cyclin Cby the observation that a significantly lower proportion
cDNA was cloned into pcDNA3, pCMV-Bam-neo, and pMT21-neo.
of Rb/ 3T3 cells could be arrested in G0 than wild- HA-tagged Rb cDNAs were mutagenized using the QuikChange XL
type 3T3 cells. Thus, even though p107 is overexpressed Site-Directed Mutagenesis system (Stratagene, La Jolla, CA). COS
in Rb/ 3T3 cells (Hurford et al., 1997), it cannot fully cell transfections were performed using Fugene 6 Transfection Re-
agent (Roche Diagnostic Corp., Indianapolis, IN) as recommendedcompensate for pRb’s absence. These observations are
by the manufacturer, and analyzed 48 hr later. SAOS-2, T98G, andalso consistent with the demonstration that acute, Cre-
3T3 cell transfections were performed using Lipofectamine Plusmediated inactivation of Rb in G0 arrested fibroblasts
Reagent (Invitrogen Corp., Carlsbad, CA) and analyzed 48–60 hrstimulates G0 exit (Sage et al., 2003). However, this is
after transfection.
not meant to imply that other pocket proteins such p130
do not also play a role in the G0/G1 transition (Canhoto RNAi
et al., 2000; Mayol et al., 1995, 1996; Moberg et al., 1996; To generate shRNA targeting cyclin C in SAOS-2 cells, complemen-
Sardet et al., 1995), and we are investigating the ability tary single strand oligonucleotides targeting cyclin C mRNA at nucle-
of cyclin C/cdk3 to phosphorylate p130, too. Also, it is otides 267–287 (GenBank accession number gi: 7382485), 5GATCC
CGTTATTGCCACTGCTACGGTTCAAGAGACCGTAGCAGTGGCAAimportant to note that S807/811 may not be the only
TAACTTTTTTGGAAA3 and 5AGCTTTTCCAAAAAAGTTATTGCCApRb sites that must undergo phosphorylation in order
CTGCTACGGTCTCTTGAACCGTAGCAGTGGCAATAACGG3, werefor cells to exit G0. For example, our MS analysis also
annealed and cloned into pSilencer-2.0-U6 (Ambion, Inc, Austin,
revealed phosphorylation of S249 in response to cyclin TX). Plasmids were introduced into cells using Lipofectamine Plus
C overexpression (data not shown). Thus, S807/811 Reagent. To suppress cyclin C expression in G0-arrested T98G cells,
phosphorylation may be necessary but not sufficient double-strand RNA oligonucleotides targeting cyclin C mRNA at
nucleotides 267–287 (GenBank accession number gi: 7382485),for G0 exit, and a more thorough mapping is currently
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were synthesized and introduced into cells using Oligofectamine CD19 and Pyronin Y, and cells stained with Pyronin Y in the absence
of APC-anti-CD19 and Hoechst dye.(Invitrogen Corp., Carlsbad, CA). To target cdk3, double-stranded
RNA oligonucleotides targeting cdk3 mRNA at nucleotides 254–274
or 350–370 (GenBank accession number gi: 4557438), were synthe- Immunoblotting
sized and also introduced into cells using oligofectamine. Whole-cell lysates (20–100 g protein) or immune precipitates were
separated by SDS-PAGE and electrophoretically transferred to
PVDF membranes (Millipore, Billerica, MA). After blocking in 10%Immune Precipitation
nonfat dry milk for 90 min at RT, they were incubated with theExcept where indicated, antibodies were coupled to protein A or
following antibodies in 2% nonfat dry milk for 2 hr at RT or overnightProtein A/G Plus agarose beads (Santa Cruz Biotechnology, Inc.,
at 4	C: rabbit antihuman cyclin C (T-19) at 1:1000; rabbit antihumanSanta Cruz, CA) by equilibrating 400 l bead suspension with an
cyclin D3 (C-16) at 1:1000; rabbit antiphosphorylated Rb at S807/811equal volume of 50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 5 mM EDTA
(Cell Signaling Technology, Beverly, MA) at 1:1000; rabbit antihumanand 0.1% NP-40 for 10 min at RT. Antibody (50 g) was added with
cdk3 (Y-20) at 1:1000; murine antihuman Rb (clone G3 245) at 1:1000;buffer to a final volume of 1 ml and mixed gently at 4	C overnight.
murine anti-HA (clone 12CA5) at 1:200; murine anti-GST (cloneBeads were washed three times with equilibration buffer, once with
DG122) at 1:200; murine antitubulin (Sigma) at 1:4000 or murine0.1 M sodium borate [pH 9.0], resuspended in 1 ml of 40 mM dimeth-
anti-FLAG M2 at 8 g/ml. Blots were then incubated with HRP-ylpimelimidate dihydrochloride in 0.1 M sodium borate [pH 9.0], and
conjugated sheep antimouse Ig or donkey antirabbit Ig at 1:2000 ingently mixed for 1 hr at RT. Beads were washed twice with 40 mM
2% nonfat dry milk for 90 min at RT. Blots were developed usingethanolamine in 0.1 M sodium borate [pH 8.0], resuspended in 1 ml
Enhanced Chemiluminescence Reagent Plus (DuPont/New Englandof 40 mM ethanolamine in 0.1 M sodium borate [pH 8.0], and mixed
Nuclear, Boston, MA). In some cases, 300 g of whole-cell lysategently at RT for 2 hr. Finally, beads were washed once with NP-40
protein was incubated with 3 l 
-phosphatase (New England Bio-lysis buffer (150 mM NaCl, 1.0% NP-40, 50 mM Tris-HCl [pH 8.0]),
labs, Beverly, MA) in 150 l of the manufacturer’s recommendedtwice with NET.N buffer (100 mM NaCl, 0.5% NP-40, 20 mM Tris-
buffer for 30 min at 30	C with or without phosphatase inhibitorsHCl [pH 8.0]), once with PBS, and then stored in PBS containing
(1 mM NaF, 0.5 mM Na3VO4, and 10 mM -glycerophosphate).0.1% sodium azide at 4	C.
Cells were lysed after washing with cold PBS by incubation in
cold NP-40 lysis buffer with protease inhibitor cocktail set I (Calbio- In Vitro Kinase Assays
chem, San Diego, CA), 1 mM NaF, 0.5 mM Na3VO4, and 10 mM To assay cyclin C-associated kinase activity, 1 mg protein from an
-glycerophosphate for 10 min on ice before collection by scraping. NP-40 lysate was incubated with 2.5 g rabbit antihuman cyclin C
The lysate was rotated for an additional 30 min at 4	C and clarified (T-19) conjugated to protein A beads for 2 hr at 4	C. Beads were
by centrifugation. Lysates containing 0.1 to 1.0 mg protein were washed twice with NP-40 lysis buffer, twice with NET.N buffer, and
precleared using conjugated normal rabbit, mouse or goat IgG at twice with kinase buffer (50 mM Tris HCl [pH 7.5], 10 mM MgCl2,
4oC for 30 min. Immune precipitations were then performed by incu- 1 mM DTT). Beads were resuspended in 20 l of kinase buffer
bating lysates overnight at 4	C with 2 to 2.5g of primary conjugated containing 13 M ATP or 20 M ATP (for assays analyzed using
antibodies. These included: rabbit anti-HA (clone Y-11), rabbit anti- phosphospecific Rb antibodies), 1l [-33P]ATP (3000 Ci/mmol, Per-
human Rb (C-15), rabbit antihuman cyclin C (T-19), rabbit antihuman kinElmer Life Sciences), 0.45g GST-Rb(379–928), GST, or a peptide
cyclin D1 (M-20), rabbit antihuman cyclin D3 (C-16), rabbit antihuman containing tandem repeats of the RNA polymerase II C-terminal
cdk3 (Y-20), and goat antihuman cdk8 (C-19) (all from Santa Cruz domain substrate site (Rickert et al., 1996). the reaction was incu-
Biotechnology, Inc.); rabbit antihuman cdk3 (Biosource, Camarillo, bated for 30 min at 30	C with occasional mixing. (Expression and
CA); rabbit antihuman cdk3 (NeoMarker, Fremont, CA); murine anti- purification of GST-Rb(379–928) and GST were performed as de-
human Rb (clone G3 245, IgG1, BD Biosciences PharMingen, San scribed (Smith and Johnson, 1988) using plasmids pGSTRb-Rb
Diego, CA); and murine anti-FLAG M2 MAb (Sigma, St. Louis, MO). (379–928) provided by Dr. W. Kaelin (Dana-Farber Cancer Institute,
Immune complexes were collected by centrifugation, washed twice Boston, MA) and pGEX-2T (Amersham Biosciences Corp., Piscata-
with NP-40 lysis buffer, twice with NET.N buffer, and once with PBS. way, NJ). The reaction was stopped by adding 10 l of 4 SDS-
Complexes were eluted by boiling beads in 1.5 SDS-PAGE sample PAGE sample buffer and boiling. Samples were resolved by SDS-
loading buffer. PAGE and electrophoretically transferred to PVDF membranes.
Membranes were exposed to BioMax MR X-ray film (Kodak, Roches-
ter, NY) to visualize phosphorylated proteins followed by immu-Cell Cycle Analysis
noblotting.To analyze DNA content, cells were suspended in chilled 80% etha-
Cyclin D1-associated kinase activity was assayed as describednol and kept at 4	C for at least 1 hour. Fixed cells were treated with
(Matsushime et al., 1994) with minor modifications. Cells were lysed500 g/ml RNase A in PBS at 37	C for 45 minutes, and then stained
in 50 mM HEPES [pH 7.5], 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA,with 69 M propidium iodide in 38 mM sodium citrate at RT for
10% glycerol and 0.1% Tween 20, and immune precipitations were30 min. DNA content was determined by flow cytometry using FACS-
performed using 200 g of protein and 15 g murine antihumancan (Becton Dickinson, Hialeah, Fla.), and data were analyzed with
cyclin D1 (clone DCS-11, NeoMarkers/Lab Vision Corp., Fremont,Cell Quest software (Becton Dickinson). For experiments involving
CA). Immune precipitates were washed four times with lysis buffer,transiently transfected cells, cells were fixed in 3% paraformalde-
and twice with cyclin D1 kinase buffer (50 mM HEPES [pH 7.5], 10 mMhyde/2% glucose in PBS on ice for 10 min and GFP cells were
MgCl2, 2.5 mM EGTA, and 1 mM DTT). Beads were resuspended ingated during FACS analysis.
15 l cyclin D1 kinase buffer supplemented with 13 M ATP, 1 lFor combined RNA and DNA analysis, cells were trypsinized,
[-33P]ATP (3000 Ci/mmol, PerkinElmer Life Sciences), 0.45 gwashed twice with Buffer I (1% FBS in PBS), resuspended at
GST-Rb(379–928) or GST, and incubated for 30 min at 30	C with0.51.0  106 cells in 1 ml of 10 g/ml Hoechst stain in Buffer I,
occasional mixing.and incubated for 40 min at 37	C. An equal volume of 0.5 g/ml
Cyclin E-associated kinase activity was assayed as describedPyronin Y in Buffer I was added directly and incubation continued
(Geng et al., 1999) with minor modifications. Immune precipitationsfor an additional 20 min. Cells were washed once with Buffer II (1%
were performed using 200g of protein from NP-40 lysates and 15lFBS and 0.01% sodium azide in PBS, [pH 7.4]), resuspended in 200
of murine antihuman cyclin E (clone HE-111) conjugated to agarosel of Buffer II, and incubated with 20 l APC-conjugated antihuman
beads (Santa Cruz Biotechnology, Inc.). Kinase assays were per-CD19 (Pharmingen) for 30 min at 4	C. (CD19 staining was only used
formed as described for cyclin C precipitates.for SAOS-2 cell transfections, not T98G or 3T3 cell transfections.)
Cells were washed once with Buffer I and analyzed using a Becton
Dickinson LSR 3 Laser (HE-NE 633 nm for APC, ARGON 488 nm for RT-PCR
For RNA preparation, SAOS-2 cells were cotransfected with humanPyronin Y, and HE-CAD 325 nm for Hoechst stain). Gates were set
using empty vector-transfected SAOS-2 cells stained with APC- CD19 and the indicated plasmids. Transfectants were isolated using
antihuman CD19 magnetic beads (Dynabeads, Dynal Biotech, Lakeconjugated anti-CD19 in the absence of Pyronin Y and Hoechst
staining, cells stained with Hoechst in the absence of APC-anti- Success, NY) and RNA was extracted using the RNeasy Mini Kit
Cell
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(Qiagen). cDNA was synthesized from 5 ng of total RNA by using berg, R.A. (1992). Regulation of retinoblastoma protein functions by
ectopic expression of human cyclins. Cell 70, 993–1006.oligo-dT16 (Applied Biosystems, Foster City, CA) and Sensiscript
Reverse Transcriptase (Qiagen). PCR was performed for 27–30 cy- Hurford, R.K., Jr., Cobrinik, D., Lee, M.H., and Dyson, N. (1997). pRB
cles by using Taq PCR Master Mix (Qiagen). The followed primers and p107/p130 are required for the regulated expression of different
were employed: GAPDH, positions 221–240 and 459–480 (GenBank sets of E2F responsive genes. Genes Dev. 11, 1447–1463.
accession number gi: 182976); c-fos, positions 100–120 and 444–467
Knudsen, E.S., and Wang, J.Y. (1996). Differential regulation of
(GenBank accession number gi: 182734); TK, positions 216–237 and
retinoblastoma protein function by specific Cdk phosphorylation
396–417 (GenBank accession number gi: 339708); DHFR, positions
sites. J. Biol. Chem. 271, 8313–8320.
640–659 and 820–839 (GenBank accession number gi: 7262376);
Kuchin, S., Yeghiayan, P., and Carlson, M. (1995). Cyclin-dependentE2F-1, positions 414–435 and 686–706 (GenBank accession number
protein kinase and cyclin homologs SSN3 and SSN8 contribute togi: 181917); and cyclin E, positions 341–360 and 642–660 (GenBank
transcriptional control in yeast. Proc. Natl. Acad. Sci. USA 92, 4006–accession number gi: 181248).
4010.
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